May 21, 2013
In a St. Joseph's Healthscene report, some popular arthritis drugs, known as TNF blockers, do not appear to increase the risk of cancer. Some research had suggested the drugs raise the danger of the disease, especially lung cancer and lymphoma, by toning down the immune system. But a new analysis of previous studies found no increase in risk.
